Live or let die: the cell's response to p53

[1]  K. Vousden,et al.  Characterization of Structural p53 Mutants Which Show Selective Defects in Apoptosis but Not Cell Cycle Arrest , 1998, Molecular and Cellular Biology.

[2]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[3]  Yusuke Nakamura,et al.  A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage , 2000, Nature.

[4]  David I. Smith,et al.  Role for the p53 homologue p73 in E2F-1-induced apoptosis , 2000, Nature.

[5]  T. Jacks,et al.  Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[7]  F. McCormick,et al.  Phosphoinositide 3-OH Kinase (PI3K) and PKB/Akt Delay the Onset of p53-mediated, Transcriptionally Dependent Apoptosis* , 1999, The Journal of Biological Chemistry.

[8]  K. Helin,et al.  Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.

[9]  Xin Lu,et al.  RB regulates the stability and the apoptotic function of p53 via MDM2. , 1999, Molecular cell.

[10]  D. Thorley-Lawson,et al.  A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.

[11]  G. Evan,et al.  Oncogenes and cell death. , 1994, Current opinion in genetics & development.

[12]  C. Harris,et al.  APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. , 2001, Cancer research.

[13]  K. Kinzler,et al.  Ferredoxin reductase affects p53-dependent, 5-fluorouracil–induced apoptosis in colorectal cancer cells , 2001, Nature Medicine.

[14]  M. Oren,et al.  Specific loss of apoptotic but not cell‐cycle arrest function in a human tumor derived p53 mutant. , 1996, The EMBO journal.

[15]  B. Foster,et al.  Pharmacological rescue of mutant p53 conformation and function. , 1999, Science.

[16]  G. Evan,et al.  Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.

[17]  G. Dotto,et al.  p21(WAF1/Cip1): more than a break to the cell cycle? , 2000, Biochimica et biophysica acta.

[18]  Ettore Appella,et al.  ATM Mediates Phosphorylation at Multiple p53 Sites, Including Ser46, in Response to Ionizing Radiation* , 2002, The Journal of Biological Chemistry.

[19]  K. Miura,et al.  The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Gusterson,et al.  A common polymorphism acts as an intragenic modifier of mutant p53 behaviour , 2000, Nature Genetics.

[21]  Arnold J Levine,et al.  p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. , 2002, Genes & development.

[22]  R. Iggo,et al.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Levine,et al.  The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.

[24]  B. Kennedy,et al.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.

[25]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[26]  L. Mayo,et al.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  V. Rotter,et al.  Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. , 2000, Cancer research.

[28]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[29]  Yusuke Nakamura,et al.  A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis , 1997, Oncogene.

[30]  S. Lowe,et al.  PML is induced by oncogenic ras and promotes premature senescence. , 2000, Genes & development.

[31]  Karen H. Vousden,et al.  The ins and outs of p53 , 2000, Nature Cell Biology.

[32]  G. Evan,et al.  Apoptosis regulators and their role in tumorigenesis. , 2001, Biochimica et biophysica acta.

[33]  J Salvage,et al.  A matter of life and death. , 1981, Nursing times.

[34]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[35]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[36]  C. Prives,et al.  Why Is p53 Acetylated? , 2001, Cell.

[37]  C. Prives,et al.  Getting p53 Out of the Nucleus , 2001, Science.

[38]  C. Holden,et al.  Death Star , 1995, Science.

[39]  Yusuke Nakamura,et al.  p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53 , 2000, Cell.

[40]  K. Kinzler,et al.  Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Sakaguchi,et al.  DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.

[42]  J P Luzio,et al.  Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. , 1998, Science.

[43]  C. Prives,et al.  A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis , 1996, Molecular and cellular biology.

[44]  Kristian Helin,et al.  APAF 1 is a key transcriptional target for p 53 in the regulation of neuronal cell death , 2001 .

[45]  A. Levine,et al.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. , 1999, Genes & development.

[46]  Yoichi Taya,et al.  Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.

[47]  T. Taniguchi,et al.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.

[48]  Yunping Lin,et al.  Pidd, a new death-domain–containing protein, is induced by p53 and promotes apoptosis , 2000, Nature Genetics.

[49]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[50]  Erwin G. Van Meir,et al.  Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells , 1994, Nature Genetics.

[51]  S. Velasco-Miguel,et al.  Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.

[52]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[53]  Xinbin Chen,et al.  p73 is transcriptionally regulated by DNA damage, p53, and p73 , 2001, Oncogene.

[54]  A. Levine,et al.  Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy , 1999, Oncogene.

[55]  C. Prives,et al.  P53 and PML: new partners in tumor suppression. , 2001, Trends in cell biology.

[56]  P. Pandolfi,et al.  The function of PML in p 53-dependent apoptosis , 2000 .

[57]  Pier Paolo Pandolfi,et al.  PML regulates p53 acetylation and premature senescence induced by oncogenic Ras , 2000, Nature.

[58]  D. Woods,et al.  Regulation of p53 function. , 2001, Experimental cell research.

[59]  N. Shikama,et al.  A novel cofactor for p300 that regulates the p53 response. , 1999, Molecular cell.

[60]  W. Kaelin,et al.  p53 family update: p73 and p63 develop their own identities. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[61]  Sam W. Lee,et al.  p53 induction of heparin‐binding EGF‐like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades , 2001, The EMBO journal.

[62]  Xin Lu,et al.  Mdm2 Inhibits the Apoptotic Function of p53 Mainly by Targeting It for Degradation* , 2000, The Journal of Biological Chemistry.

[63]  T. Mak,et al.  Regulation of PTEN transcription by p53. , 2001, Molecular cell.

[64]  K. Vousden.  Activation of the p53 tumor suppressor protein. , 2002, Biochimica et biophysica acta.

[65]  K. Vousden,et al.  Activation and activities of the p53 tumour suppressor protein , 2001, British Journal of Cancer.

[66]  K. Sakaguchi,et al.  Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation , 1999, The EMBO journal.

[67]  J. Blenis,et al.  Essential Role for Caspase-8 in Transcription-independent Apoptosis Triggered by p53* , 2000, The Journal of Biological Chemistry.

[68]  N. Perkins,et al.  Transcriptional Cross Talk between NF-κB and p53 , 1999, Molecular and Cellular Biology.

[69]  R. Klinke,et al.  A Chemical Inhibitor of p 53 That Protects Mice from the Side Effects of Cancer Therapy , 1999 .

[70]  S. Lowe,et al.  Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. , 1999, Science.

[71]  M. Fiscella,et al.  Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[72]  K. Vousden,et al.  Minireviewp 53 : Death Star able to induce the defensive p 53 response to oncogene , 2000 .

[73]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[74]  C. Prives,et al.  p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells , 1999, Molecular and Cellular Biology.

[75]  Galina Selivanova,et al.  Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound , 2002, Nature Medicine.

[76]  M. Oren,et al.  Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformation , 2001, The EMBO journal.

[77]  E. Shaulian,et al.  Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.

[78]  G. Melino,et al.  Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53 , 2001, Cell Death and Differentiation.

[79]  J. Espinosa,et al.  Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. , 2001, Molecular cell.

[80]  M. Vitek,et al.  Akt Activation Protects Hippocampal Neurons from Apoptosis by Inhibiting Transcriptional Activity of p53* , 2001, The Journal of Biological Chemistry.

[81]  R. Ribeiro,et al.  A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer , 2002, Nature Structural Biology.

[82]  Y. Sun,et al.  Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter , 1997, Molecular and cellular biology.

[83]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[84]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[85]  Ailan Guo,et al.  The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.

[86]  G. Melino,et al.  p73: Friend or foe in tumorigenesis , 2002, Nature Reviews Cancer.

[87]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[88]  E. May,et al.  Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice , 2000, Oncogene.

[89]  A. Fornace,et al.  Analysis of the mammalian gadd45 gene and its response to DNA damage. , 1993, The Journal of biological chemistry.

[90]  R. Berger,et al.  Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway , 1996, Nature Genetics.

[91]  K. Kinzler,et al.  Identification and classification of p 53-regulated genes , 1999 .

[92]  K. Vousden,et al.  Transcriptional activation by p53 correlates with suppression of growth but not transformation , 1994, Cell.

[93]  M. Kapoor,et al.  High metastatic potential in mice inheriting a targeted p53 missense mutation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[94]  K. Tsai,et al.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage , 2002, Nature.

[95]  D. Beach,et al.  Cyclin G is a transcriptional target of the p53 tumor suppressor protein. , 1994, The EMBO journal.

[96]  G. Wahl,et al.  A transactivation-deficient mouse model provides insights into Trp53 regulation and function , 2000, Nature Genetics.

[97]  Judith Roth,et al.  A polymorphic microsatellite that mediates induction of PIG3 by p53 , 2002, Nature Genetics.

[98]  The ins and outs of p 53 , .

[99]  Yong Liao,et al.  HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation , 2001, Nature Cell Biology.

[100]  N D Marchenko,et al.  Death Signal-induced Localization of p53 Protein to Mitochondria , 2000, The Journal of Biological Chemistry.

[101]  G. Zambetti,et al.  ei24, a p53 Response Gene Involved in Growth Suppression and Apoptosis , 2000, Molecular and Cellular Biology.

[102]  L. Cantley,et al.  The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. , 2001, Molecular cell.

[103]  D. Green,et al.  Mechanisms of p53-dependent apoptosis. , 2001, Biochemical Society transactions.

[104]  C. Harris,et al.  Mutational spectrum of the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Drug metabolism reviews.

[105]  P. Pandolfi,et al.  Regulation of p53 activity in nuclear bodies by a specific PML isoform , 2000, The EMBO journal.

[106]  K. Miura,et al.  The expression of the KAI 1 gene , a tumor metastasis suppressor , is directly activated by p 53 , 1998 .

[107]  T. Jacks,et al.  Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells. , 1996, Oncogene.

[108]  M. Oren,et al.  Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities* , 2002, The Journal of Biological Chemistry.

[109]  S. Lowe,et al.  PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. , 2000, Genes & development.

[110]  X. Chen,et al.  p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. , 1996, Genes & development.

[111]  C. C. Harris,et al.  p53-Mediated Apoptosis and Genomic Instability Diseases , 2001, Acta oncologica.

[112]  M. Oren,et al.  mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.

[113]  D. Yap,et al.  Novel Function of the Cyclin A Binding Site of E2F in Regulating p53-Induced Apoptosis in Response to DNA Damage , 2002, Molecular and Cellular Biology.

[114]  M. Karin,et al.  p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.

[115]  I. Krantz,et al.  KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene , 1997, Nature Genetics.

[116]  A. Levine,et al.  WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. , 2002, Genes & development.

[117]  A. Fornace,et al.  The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[118]  Xin Lu,et al.  ASPP proteins specifically stimulate the apoptotic function of p53. , 2001, Molecular cell.

[119]  W. El-Deiry,et al.  p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. , 1998, Cancer research.

[120]  Valerie Reinke,et al.  Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 , 2001, Nature Genetics.

[121]  M. Fiscella,et al.  Wip 1 , a novel human protein phosphatase that is induced in response to ionizing radiation in a p 53-dependent manner , 1997 .

[122]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[123]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[124]  M. Oren,et al.  mdm 2 expression is induced by wild type p 53 activity , 2004 .

[125]  K. Vousden,et al.  A ribonucleotide reductase gene is a transcriptional target of p53 and p73 , 2000, Oncogene.

[126]  Ana I. Robles, Curtis C. Harris.  p53-Mediated Apoptosis and Genomic Instability Diseases , 2001 .

[127]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[128]  J. Pietenpol,et al.  Kinetics of p53 Binding to Promoter Sites In Vivo , 2001, Molecular and Cellular Biology.

[129]  A. Levine,et al.  Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73* , 2000, The Journal of Biological Chemistry.

[130]  K. Vousden,et al.  Role of NF-κB in p53-mediated programmed cell death , 2000, Nature.

[131]  David S. Park,et al.  APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death , 2001, The Journal of cell biology.

[132]  E. Appella,et al.  p53 transcriptional activity is essential for p53‐dependent apoptosis following DNA damage , 2000, The EMBO journal.

[133]  L. Donehower,et al.  Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors , 1993, Cell.

[134]  Jiawei Han,et al.  Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[135]  Lawrence A. Donehower,et al.  A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient mice , 1995, Nature Genetics.

[136]  J. Roth,et al.  Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression , 1995, Molecular and cellular biology.

[137]  G. Blandino,et al.  DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. , 2002, Molecular cell.

[138]  M. Murphy,et al.  The Corepressor mSin3a Interacts with the Proline-Rich Domain of p53 and Protects p53 from Proteasome-Mediated Degradation , 2001, Molecular and Cellular Biology.

[139]  A. Fersht,et al.  A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[140]  B. Pützer,et al.  Role of the p53-homologue p73 in E2F1-induced apoptosis , 2000, Nature Genetics.

[141]  K. Kinzler,et al.  PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.

[142]  S. Korsmeyer,et al.  Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis , 2001, Molecular and Cellular Biology.

[143]  K. Vousden,et al.  E2F-1 induced apoptosis , 2001, Apoptosis.

[144]  E. Appella,et al.  p53 Regulates the Expression of the Tumor Suppressor Gene Maspin* , 2000, The Journal of Biological Chemistry.

[145]  Guillermina Lozano,et al.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.

[146]  Yaolin Wang,et al.  Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches* 210 , 2001, The Journal of Biological Chemistry.

[147]  Giulia Piaggio,et al.  Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis , 2002, Nature Cell Biology.

[148]  G. Getz,et al.  DNA microarrays identification of primary and secondary target genes regulated by p53 , 2001, Oncogene.

[149]  N. Hay,et al.  Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.

[150]  Masaaki Adachi,et al.  p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.

[151]  J. Piette,et al.  Anti‐apoptotic activity of low levels of wild‐type p53. , 1996, The EMBO journal.

[152]  Lawrence A. Donehower,et al.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.

[153]  M V Chernov,et al.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.

[154]  W. Kaelin,et al.  A common E2F-1 and p73 pathway mediates cell death induced by TCR activation , 2000, Nature.

[155]  J. Varley,et al.  Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family , 1997, Oncogene.

[156]  C. Prives,et al.  A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain , 2001, Molecular and Cellular Biology.

[157]  Y Taya,et al.  p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. , 2001, Molecular cell.

[158]  D. Notterman,et al.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.

[159]  K. Vousden,et al.  Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function , 1996, Molecular and cellular biology.